索引超出了数组界限。
[1] Ozaki E, Campbell M, Doyle SL. Targeting the NLRP3 inflammasome in chronic inflammatory diseases: current perspectives[J]. J Inflamm Res, 2015, 8: 15-27.
[2] Wree A, Eguchi A, McGeough MD, et al. NLRP3 inflammasome activation results in hepatocyte pyroptosis, liver inflammation, and fibrosis in mice[J]. Hepatology, 2014, 59(3): 898-910.
[3] Latz E, Xiao TS, Stutz A. Activation and regulation of the inflammasomes[J]. Nat Rev Immunol, 2013, 13(6): 397-411.
[4] Chang W, Lin J, Dong J, et al. Pyroptosis: an inflammatory cell death implicates in atherosclerosis[J]. Med Hypotheses, 2013, 81(3): 484-486.
[5] Qiao Y, Wang P, Qi J, et al. TLR-induced NF-kappaB activation regulates NLRP3 expression in murine macrophages[J]. FEBS Lett, 2012, 586(7): 1022-1026.
[6] Mishra BB, Rathinam VA, Martens GW, et al. Nitric oxide controls the immunopathology of tuberculosis by inhibiting NLRP3 inflammasome-dependent processing of IL-1beta[J]. Nat Immunol, 2013, 14(1): 52-60.
[7] Jefferies C, Wynne C, Higgs R. Antiviral TRIMs: friend or foe in autoimmune and autoinflammatory disease?[J]. Nat Rev Immunol, 2011, 11(9): 617-625.
[8] Shi CS, Shenderov K, Huang NN, et al. Activation of autophagy by inflammatory signals limits IL-1beta production by targeting ubiquitinatedinflammasomes for destruction[J]. Nat Immunol, 2012, 13(3): 255-263.
[9] Deretic V, Saitoh T, Akira S. Autophagy in infection, inflammation and immunity[J]. Nat Rev Immunol, 2013, 13(10): 722-737.
[10] Harris J. Autophagy and IL-1 family cytokines[J]. Front Immunol, 2013, 4: 83.
[11] Abderrazak A, Syrovets T, Couchie D, et al. NLRP3 inflammasome: From a danger signal sensor to a regulatory node of oxidative stress and inflammatory diseases[J]. Redox Biol, 2015, 4: 296-307.
[12] Duewell P, Kono H, Rayner KJ, et al. NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals[J]. Nature, 2010, 464(7293): 1357-1361.
[13] 于 佳, 倪唤春,罗心平. 脂质代谢相关基因多态性与动脉粥样硬化[J]. 国际心血管病杂志, 2014, 41(3): 173-175.
[14] Ding Z, Liu S, Wang X, et al. LOX-1, mtDNA damage, and NLRP3 inflammasome activation in macrophages: implications in atherogenesis[J]. Cardiovasc Res, 2014, 103(4): 619-628.
[15] Zhou R, Tardivel A, Thorens B, et al. Thioredoxin-interacting protein links oxidative stress to inflammasome activation[J]. Nat Immunol, 2010, 11(2): 136-140.
[16] Zhao P, Liu J, Pan C, et al. NLRP3 inflammasome is required for apoptosis of Aggregatibacter actinomycetemcomitans-infected human osteoblastic MG63 cells[J]. Acta Histochem, 2014, 116(7): 1119-1124.
[17] Kirii H, Niwa T, Yamada Y, et al. Seishima M. Lack of interleukin-1beta decreases the severity of atherosclerosis in ApoE-deficient mice[J]. Arterioscler Thromb Vasc Biol, 2003, 23(4): 656-660.
[18] Merhi-Soussi F, Kwak BR, Magne D, et al. Interleukin-1 plays a major role in vascular inflammation and atherosclerosis in male apolipoprotein E-knockout mice[J]. Cardiovasc Res, 2005, 66(3):583-593.
[19] Usui F, Shirasuna K, Kimura H, et al. Critical role of caspase-1 in vascular inflammation and development of atherosclerosis in Western diet-fed apolipoprotein E-deficient mice[J]. Biochem Biophys Res Commun, 2012, 425(2): 162-168.
[20] Menu P, Pellegrin M, Aubert JF, et al. Atherosclerosis in ApoE-deficient mice progresses independently of the NLRP3 inflammasome[J]. Cell Death Dis, 2011, 2:e137.
[21] Staal J, Bekaert T,Beyaert R. Regulation of NF-kappaB signaling by caspases and MALT1 paracaspase[J]. Cell Res, 2011, 21(1): 40-54.
[22] Zheng F, Xing S, Gong Z, et al. Silence of NLRP3 Suppresses Atherosclerosis and Stabilizes Plaques in Apolipoprotein E-Deficient Mice[J]. Mediators Inflamm, 2014, 2014: 507208.
[23] Xiao H, Lu M, Lin TY, et al. Sterol regulatory element binding protein 2 activation of NLRP3 inflammasome in endothelium mediates hemodynamic-induced atherosclerosis susceptibility[J]. Circulation, 2013, 128(6): 632-642.
[24] Peng K, Liu L, Wei D, et al. P2X7R is involved in the progression of atherosclerosis by promoting NLRP3 inflammasome activation [J]. Int J Mol Med, 2015, 35(5): 1179-1188.